Deals
Takeda Plans Sale of Tachosil in Shire Divestment
- Tachosil surgical patches may fetch $500 million in a sale
- Japanese drugmaker is planning to divest $10 billion in assets
This article is for subscribers only.
Takeda Pharmaceutical Co. is planning a sale of its Tachosil brand of surgical patches and sealants as it looks to cut debt after its $62 billion takeover of Shire Plc, people familiar with the matter said.
Tachosil could fetch about $500 million in a sale, said the people, who asked not to be identified because the deliberations are private. The asset has attracted interest from bidders including Baxter International Inc. and Johnson & Johnson, according to the people.